Florida is cutting the most popular HIV medication from the drugs state-subsidized patients can get. State officials cite the end of federal ACA subsidies and rising drug costs for the changes. New ...
Since its founding in 2016, the University of Maryland SAFE Center has helped more than 600 survivors of sex and labor trafficking rebuild their lives — a milestone driven by CEO and founder Susan ...
KLAIPEDA, Lithuania—Germany’s top military officer, Gen. Carsten Breuer, stood astride a map of Lithuania laid out on the floor of a makeshift command post in this port city on the Baltic Sea. A chill ...
The case for replacing age-based breast cancer screening with personalized risk-based screening is gaining strength — with recent studies showing the approach is feasible and has the potential to save ...
Germany economy had shrunk in last two years Chancellor Merz rolling out huge fiscal stimulus Growth driven by household consumption and government spending Investment down 0.5%, machinery and ...
It’s not every day New Yorkers line up in the predawn chill to get their hands on some hot new German goods. But that’s exactly what happened on a November morning in downtown Brooklyn. Adrianne ...
A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms for all, women were screened based on genetics, health history, and ...
Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, a new study says. Women had breast cancers caught at an earlier, more treatable stage ...
A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch the disease. In a study published in JAMA and presented at the San Antonio ...
About The Study: In a randomized clinical trial, researchers found risk-based breast cancer screening was as safe as annual screening for detecting advanced cancers but did not reduce breast biopsy ...
SAN ANTONIO -- Risk-based breast cancer screening proved noninferior for detecting clinically significant tumors in a randomized trial, though outside experts raised concerns and a major medical group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results